TFAP4 Gene - Transcription Factor AP-4

Basic helix-loop-helix transcription factor involved in cell proliferation, differentiation, and cancer

Gene Information Card

Symbol TFAP4
Full Name Transcription Factor AP-4
Gene Type Protein coding
Chromosomal Location 16p13.3
NCBI Gene ID 7023 ncbi.nlm.nih.gov/gene/7023
Ensembl ID ENSG00000100033
UniProt ID Q01664
OMIM ID 600743
HGNC ID 11744
Aliases AP-4, bHLHc41, SEF2-1B, SEF2-1B1

Description

TFAP4 (Transcription Factor AP-4) encodes a basic helix-loop-helix (bHLH) transcription factor that binds to the E-box motif (5'-CAGCTG-3') and regulates genes involved in cell proliferation, differentiation, and apoptosis. It is widely expressed and plays roles in neurodevelopment, immune function, and cancer progression. TFAP4 can act as both an oncogene and a tumor suppressor depending on cellular context.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Colorectal cancer TFAP4 overexpression promotes Wnt/β-catenin signaling and cell proliferation PMID: 25605248
Breast cancer TFAP4 regulates epithelial-mesenchymal transition (EMT) and metastasis PMID: 27323850
Gastric cancer TFAP4 upregulation correlates with poor prognosis and invasion PMID: 28397828
Neuroblastoma TFAP4 expression associated with MYCN amplification and tumor progression PMID: 21575862
Hepatocellular carcinoma TFAP4 promotes cell cycle progression via cyclin D1 PMID: 29323341

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Colon 15.3 Medium
Breast 8.7 Low
Liver 6.2 Low
Lung 10.1 Medium
Stomach 14.0 Medium
Kidney 9.4 Low
Testis 18.6 High
Cell Line Expression
Cell Line nTPM Notes
HEK293 22.3 Embryonic kidney, high expression
HeLa 16.8 Cervical carcinoma, moderate expression
HCT116 25.1 Colorectal carcinoma, high expression
MCF7 11.4 Breast carcinoma, moderate expression
A549 9.7 Lung carcinoma, low expression
SH-SY5Y 14.2 Neuroblastoma, moderate expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.487C>T (p.Arg163Trp) Missense 0.02% (COSMIC) Altered DNA-binding affinity
c.632G>A (p.Arg211Gln) Missense 0.01% (COSMIC) Unknown functional impact
c.1003_1004insA (p.Thr335Asnfs*12) Frameshift 0.005% (COSMIC) Loss of function
c.1A>G (p.Met1Val) Start loss 0.003% (ClinVar) Loss of function
Mutation functional classification

Loss of Function (LOF)

Frameshift and start-loss mutations (e.g., p.Thr335Asnfs*12, p.Met1Val) result in truncated or absent protein, reducing transcriptional activity.

Gain of Function (GOF)

Missense mutations in the bHLH domain (e.g., p.Arg163Trp) may enhance DNA binding or dimerization, potentially increasing oncogenic signaling.

Dominant Negative (DN)

No well-characterized dominant-negative mutations reported; some missense variants may interfere with wild-type TFAP4 dimerization.

Pathways

• Wnt signaling pathway (Reactome: R-HSA-195721)
• Transcriptional regulation by bHLH factors (Reactome: R-HSA-9616222)
• p53 pathway (Reactome: R-HSA-5633007)
• Cell cycle (Reactome: R-HSA-1640170)

Protein Summary

TFAP4 encodes a 340-amino acid basic helix-loop-helix (bHLH) transcription factor that forms homodimers or heterodimers with other bHLH proteins. It binds E-box sequences (5'-CAGCTG-3') to regulate target genes involved in cell cycle control, differentiation, and apoptosis. The protein contains a bHLH domain (residues 155-207) and a leucine zipper motif. Post-translational modifications include phosphorylation and ubiquitination, which modulate its stability and activity. TFAP4 is implicated in several cancers, where it can promote proliferation or suppress apoptosis depending on cellular context.

Related Products

Product name Cat.No. Species Gene ID
TFAP4 Knockout HEK293 Cell Line EDJ-KQ15710 Human 7023 Details Get a Quote
TFAP4 Knockout A-549 Cell Line EDJ-KQ46615 Human 7023 Details Get a Quote
TFAP4 Knockout HCT 116 Cell Line EDJ-KQ46616 Human 7023 Details Get a Quote
TFAP4 Knockout HeLa Cell Line EDJ-KQ46617 Human 7023 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: